Fulcrum Capital LLC Baxter International Inc Transaction History

Fulcrum Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	SELL	$39.98 - $47.68 $125,057 - $149,143	-3,128 Reduced 15.51%	17,041 $776,000
Q1 2023 May 10, 2023	SELL	$37.58 - $52.57 $108,869 - $152,295	-2,897 Reduced 12.56%	20,169 $818,000
Q4 2022 Jan 24, 2023	SELL	$49.7 - $57.71 $58,198 - $67,578	-1,171 Reduced 4.83%	23,066 $0
Q3 2022 Oct 17, 2022	SELL	$53.86 - $66.8 $32,800 - $40,681	-609 Reduced 2.45%	24,237 $1.31 Million
Q2 2022 Aug 03, 2022	BUY	$63.83 - $80.0 $1.59 Million - $1.99 Million	24,846 New	24,846 $1.6 Million

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Fulcrum Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Fulcrum Capital LLC with notifications on news.